Concepts (94)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Coronary Artery Disease | 4 | 2022 | 274 | 0.850 |
Why?
|
| Embolism, Paradoxical | 1 | 2021 | 13 | 0.730 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2022 | 51 | 0.720 |
Why?
|
| Foramen Ovale, Patent | 1 | 2021 | 13 | 0.720 |
Why?
|
| Pulmonary Embolism | 3 | 2021 | 169 | 0.670 |
Why?
|
| ST Elevation Myocardial Infarction | 1 | 2021 | 73 | 0.670 |
Why?
|
| Thrombosis | 2 | 2021 | 187 | 0.630 |
Why?
|
| Anticholesteremic Agents | 1 | 2019 | 34 | 0.630 |
Why?
|
| American Heart Association | 1 | 2019 | 122 | 0.600 |
Why?
|
| Atherosclerosis | 1 | 2019 | 146 | 0.570 |
Why?
|
| Medication Adherence | 1 | 2019 | 241 | 0.540 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 706 | 0.460 |
Why?
|
| Cardiomyopathy, Hypertrophic | 2 | 2023 | 753 | 0.450 |
Why?
|
| Physicians | 1 | 2019 | 442 | 0.430 |
Why?
|
| Electrocardiography | 4 | 2023 | 524 | 0.290 |
Why?
|
| Death | 1 | 2022 | 25 | 0.190 |
Why?
|
| Angioplasty, Balloon, Coronary | 2 | 2020 | 168 | 0.180 |
Why?
|
| Thioctic Acid | 1 | 2020 | 7 | 0.180 |
Why?
|
| Echocardiography | 2 | 2023 | 458 | 0.170 |
Why?
|
| Dipeptides | 1 | 2020 | 60 | 0.170 |
Why?
|
| Myocytes, Cardiac | 1 | 2020 | 88 | 0.170 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2022 | 205 | 0.160 |
Why?
|
| Cardiovascular Agents | 1 | 2020 | 98 | 0.160 |
Why?
|
| Cholesterol, LDL | 1 | 2019 | 102 | 0.150 |
Why?
|
| Humans | 16 | 2023 | 59473 | 0.150 |
Why?
|
| Biomarkers | 2 | 2020 | 1306 | 0.140 |
Why?
|
| Coronary Thrombosis | 1 | 1996 | 18 | 0.130 |
Why?
|
| Heart Block | 1 | 1996 | 22 | 0.130 |
Why?
|
| Heart Atria | 1 | 1996 | 136 | 0.120 |
Why?
|
| Azygos Vein | 1 | 1995 | 4 | 0.120 |
Why?
|
| Congenital Abnormalities | 1 | 1995 | 23 | 0.120 |
Why?
|
| Cardiac Tamponade | 1 | 1995 | 12 | 0.120 |
Why?
|
| Vena Cava, Inferior | 1 | 1995 | 28 | 0.120 |
Why?
|
| Aged | 7 | 2020 | 13424 | 0.110 |
Why?
|
| Death, Sudden, Cardiac | 1 | 1996 | 349 | 0.100 |
Why?
|
| Risk Factors | 1 | 2022 | 4989 | 0.100 |
Why?
|
| Paclitaxel | 1 | 2010 | 90 | 0.080 |
Why?
|
| Sirolimus | 1 | 2010 | 88 | 0.080 |
Why?
|
| United States | 2 | 2020 | 7432 | 0.080 |
Why?
|
| Drug-Eluting Stents | 1 | 2010 | 53 | 0.080 |
Why?
|
| Hypertension | 1 | 1995 | 570 | 0.080 |
Why?
|
| Female | 8 | 2020 | 30775 | 0.080 |
Why?
|
| Male | 8 | 2020 | 27796 | 0.070 |
Why?
|
| Retrospective Studies | 1 | 2019 | 6084 | 0.070 |
Why?
|
| Coitus | 1 | 2004 | 15 | 0.060 |
Why?
|
| Obesity, Morbid | 1 | 2004 | 92 | 0.050 |
Why?
|
| Myocardial Infarction | 2 | 2010 | 863 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2020 | 3071 | 0.050 |
Why?
|
| Time Factors | 2 | 2020 | 3621 | 0.040 |
Why?
|
| Creatine Kinase, MB Form | 1 | 2020 | 9 | 0.040 |
Why?
|
| Coronary Vessels | 2 | 2004 | 109 | 0.040 |
Why?
|
| Troponin T | 1 | 2020 | 23 | 0.040 |
Why?
|
| India | 1 | 2020 | 150 | 0.040 |
Why?
|
| Necrosis | 1 | 2020 | 140 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2020 | 713 | 0.040 |
Why?
|
| Echocardiography, Transesophageal | 2 | 1996 | 92 | 0.040 |
Why?
|
| Middle Aged | 5 | 2020 | 16337 | 0.030 |
Why?
|
| Superior Vena Cava Syndrome | 1 | 1996 | 7 | 0.030 |
Why?
|
| Cardiac Catheterization | 2 | 1995 | 253 | 0.030 |
Why?
|
| Myocardial Ischemia | 1 | 1996 | 111 | 0.030 |
Why?
|
| Pulmonary Emphysema | 1 | 1996 | 99 | 0.030 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 1995 | 8 | 0.030 |
Why?
|
| Pulse | 1 | 1995 | 15 | 0.030 |
Why?
|
| Phlebography | 1 | 1995 | 43 | 0.030 |
Why?
|
| Embolism | 1 | 1995 | 39 | 0.030 |
Why?
|
| Tachycardia | 1 | 1994 | 28 | 0.030 |
Why?
|
| Antihypertensive Agents | 1 | 1995 | 163 | 0.030 |
Why?
|
| Blood Pressure | 1 | 1995 | 496 | 0.020 |
Why?
|
| Everolimus | 1 | 2010 | 21 | 0.020 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2010 | 23 | 0.020 |
Why?
|
| Retreatment | 1 | 2010 | 46 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2010 | 136 | 0.020 |
Why?
|
| Angiography | 2 | 2004 | 145 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2020 | 5292 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2010 | 185 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 2004 | 934 | 0.020 |
Why?
|
| Logistic Models | 1 | 2010 | 1236 | 0.020 |
Why?
|
| Pain | 1 | 2004 | 397 | 0.010 |
Why?
|
| Cardiac Complexes, Premature | 1 | 1994 | 1 | 0.010 |
Why?
|
| Emergencies | 1 | 1995 | 110 | 0.010 |
Why?
|
| Tachycardia, Supraventricular | 1 | 1994 | 9 | 0.010 |
Why?
|
| Bundle-Branch Block | 1 | 1994 | 14 | 0.010 |
Why?
|
| Pulmonary Artery | 1 | 1995 | 88 | 0.010 |
Why?
|
| Mitral Valve Insufficiency | 1 | 1995 | 74 | 0.010 |
Why?
|
| Hemodynamics | 1 | 1995 | 230 | 0.010 |
Why?
|
| Adult | 2 | 2004 | 15698 | 0.010 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 1995 | 113 | 0.010 |
Why?
|
| Acute Disease | 1 | 1995 | 660 | 0.010 |
Why?
|
| Radiography | 1 | 1995 | 517 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 1995 | 254 | 0.010 |
Why?
|
| Heart Rate | 1 | 1994 | 307 | 0.010 |
Why?
|
| Tachycardia, Ventricular | 1 | 1994 | 120 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 1994 | 1561 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 1995 | 5125 | 0.000 |
Why?
|